Aim
To describe presentation and outcome of SoJIA and to determine early clinical and laboratory characteristics associated to a poor outcome.
Methods
Retrospective study on SoJIA cases diagnosed by ILAR criteria between January 1985 and December 2005 in a tertiary paediatric rheumatology centre.
Results
During the study period, 114 children were included. Mean age at diagnosis was 4 years and 4 months (range, 4 months to 15.5 years). Familial history of autoimmunity was found in 27% of the patients. Glycosylated ferritin was low (≤20%) for 79% of patients. Twelve percent of patients had macrophage activation syndrome, 2 patients anti-neutrophil cytoplasmic antibodies (ANCA) associated glomerulonephritis, 3 patients pulmonary restrictive syndrome without vertebral arthritis, and one patient Crohn's disease; 11 % had positive antinuclear antibody (ANA) (≥1/160) at diagnosis. None developed neoplasia. Patients in whom diagnosis was made after 2000, and had been treated by biotherapy, especially anakinra, had less osteoarticular sequelae and lower inflammatory syndrome (p = 0,004) than others (Figure 1 ). Early polyarticular and wrists involvements were associated to a poor outcome (p = 0,009, p = 0,027).
Conclusion
This retrospective study suggests that 1) autoimmunity might be involved in the pathogenesis of SoJIA 2) early polyarticular and wrist involvements are associated with a poor outcome 3) anti-IL1 agents'use is associated with an improvement of the outcome. Melki et al. Pediatric Rheumatology 2011, 9(Suppl 1):P178 http://www.ped-rheum.com/content/9/S1/P178
